Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells

Jones, Courtney L., Stevens, Brett M., D'Alessandro, Angelo, Reisz, Julie A., Culp-Hill, Rachel, Nemkov, Travis, Pei, Shanshan, Khan, Nabilah +8 more·2018·Cancer Cell

DOI 10.1016/j.ccell.2018.10.005

Cited by (591)

Items 101–200 of 591

Metabolic Regulation of Hematopoietic Stem Cells
Claudia Morganti, Nina Cabezas‐Wallscheid, Keisuke Ito · 2022 · HemaSphere
ATF3 coordinates serine and nucleotide metabolism to drive cell cycle progression in acute myeloid leukemia
Di Marcantonio, Daniela, Martinez, Esteban, Kanefsky, Joice S., Huhn, Jacklyn M., Gabbasov, Rashid, Gupta, Anushk, Krais, John J., Peri, Suraj, Tan, YinFei, Skorski, Tomasz et al. · 2021 · Molecular Cell
SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia
Dongqing Yan, Anca Franzini, Anthony D. Pomicter, Brayden J. Halverson, Orlando Antelope, Clinton C. Mason, Jonathan M. Ahmann, Anna V. Senina, Nadeem A. Vellore, Courtney L. Jones et al. · 2021 · Blood Cancer Discovery
Hematopoietic Stem Cell Factors: Their Functional Role in Self-Renewal and Clinical Aspects
Zoya Mann, Manisha Sengar, Yogesh Kumar Verma, Raja Rajalingam, Pawan Kumar Raghav · 2022 · Frontiers in Cell and Developmental Biology
Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
Jialan Niu, Danyue Peng, Lingbo Liu · 2022 · Frontiers in Oncology
Remodeling cancer stemness by collagen/fibronectin via the AKT and CDC42 signaling pathway crosstalk in glioma
Chuanhong Zhong, Bei Tao, Fangli Tang, Xiaobo Yang, Tangming Peng, Jian You, Kaiguo Xia, Xiangguo Xia, Ligang Chen, Lilei Peng · 2020 · Theranostics
Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine
Ralf Buettner, Le Xuan Truong Nguyen, Corey James Morales, Min-Hsuan Chen, Xiwei Wu, Lisa S. Chen, Dinh Hoa Hoang, Servando Hernandez Vargas, Vinod A. Pullarkat, Varsha V. Gandhi et al. · 2021 · Journal of Hematology & Oncology
Sphingosine-1-Phosphate Receptor 3 Potentiates Inflammatory Programs in Normal and Leukemia Stem Cells to Promote Differentiation
Stephanie Zhi-Juan Xie, Kerstin B. Kaufmann, Weijia Wang, Michelle Chan‐Seng‐Yue, Olga I. Gan, Elisa Laurenti, Laura García‐Prat, Shin‐ichiro Takayanagi, Stanley Ng, Changjiang Xu et al. · 2020 · Blood Cancer Discovery
The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting
Yongfeng Chen, Jing Li, Linglong Xu, Mihnea‐Alexandru Găman, Zhenyou Zou · 2022 · Cell Death Discovery
Metabolic alterations mediated by STAT3 promotes drug persistence in CML
Patel, Sweta B., Nemkov, Travis, Stefanoni, Davide, Benavides, Gloria A., Bassal, Mahmoud A., Crown, Brittany L., Matkins, Victoria R., Camacho, Virginia, Kuznetsova, Valeriya, Hoang, Ashley T. et al. · 2021 · Leukemia
Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies
Mila S Griffioen, D. D. de Leeuw, Jeroen Janssen, L. Smit · 2022 · Cancers
Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection
Xutong Qiu, Yi Li, Zhuoyuan Zhang · 2023 · Cellular Oncology
Extinguishing the Embers: Targeting AML Metabolism
Rachel Culp‐Hill, Angelo D’Alessandro, Eric Martin Pietras · 2020 · Trends in Molecular Medicine
The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia
Ayşegül Erdem, Silvia Marín, Diego A. Pereira‐Martins, Roldán Cortés, Alan Cunningham, Maurien G. M. Pruis, Bauke de Boer, Fiona A.J. van den Heuvel, Marjan Geugien, Albertus T.J. Wierenga et al. · 2022 · Nature Communications
Mechanisms of venetoclax resistance and solutions
Jiachen Liu, Yidong Chen, Lihua Yu, Lihua Yang · 2022 · Frontiers in Oncology
Targeting mitochondrial respiration for the treatment of acute myeloid leukemia
Jenna L. Carter, Katie Hege-Hurrish, Hasini A. Kalpage, Holly J. Edwards, Maik Hüttemann, Jeffrey Warren Taub, Yubin Ge · 2020 · Biochemical Pharmacology
Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia therapy
Katharina Mattes, Edo Vellenga, Hein Schepers · 2019 · Critical Reviews in Oncology/Hematology
Cell signaling pathways as molecular targets to eliminate AML stem cells
Ana Carolina Rodrigues, Rafaela G.A. Costa, Suellen L. R. Silva, Ingrid R. S. B. Dias, Rosane B. Dias, Daniel Pereira Bezerra · 2021 · Critical Reviews in Oncology/Hematology
Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
Lucille Stuani, Marie Sabatier, Jean‐Emmanuel Sarry · 2019 · BMC Biology
Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells
Josephine Wesely, Andriana G. Kotini, Franco Izzo, Hanzhi Luo, Han Yuan, Jun Sun, Maria Georgomanoli, Asaf Zviran, André G. Deslauriers, Neville N. Dusaj et al. · 2020 · Cell Reports
Fatty acid metabolism is related to the immune microenvironment changes of gastric cancer and RGS2 is a new tumor biomarker
Shifeng Yang, Boshi Sun, Wenjing Li, Hao Yang, Nana Li, Xinyu Zhang · 2022 · Frontiers in Immunology
Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy
Yilin Yu, Jie Yu, Shengfang Ge, Yun Su, Xianqun Fan · 2023 · International Journal of Biological Sciences
NAT10-mediated mRNA N4-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia
Subo Zhang, Feng Huang, Yushuai Wang, Yifei Long, Yuanpei Li, Yalin Kang, Weiwei Gao, Xiuxin Zhang, Yueting Wen, Yun Wang et al. · 2024 · Nature Cell Biology
Pairing MCL‐1 inhibition with venetoclax improves therapeutic efficiency of BH3‐mimetics in AML
Myriam Hormi, Rudy Birsen, Maya Belhadj, Tony Huynh, Lilia Cantero-Aguilar, Éric Grignano, Lamya Haddaoui, François Guillonneau, Patrick Mayeux, Mathilde Hunault et al. · 2020 · European Journal Of Haematology
Nuclear NAD + homeostasis governed by NMNAT1 prevents apoptosis of acute myeloid leukemia stem cells
Xiangguo E. Shi, Yajian Jiang, Ayumi Kitano, Tianyuan Hu, Rebecca L. Murdaugh, Yuan Li, Kevin A. Hoegenauer, Rui Chen, Koichi Takahashi, Daisuke Nakada · 2021 · Science Advances
Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability
Ayşegül Erdem, Silvia Marín, Diego A. Pereira‐Martins, Marjan Geugien, Alan Cunningham, Maurien G. M. Pruis, Isabel Weinhäuser, Albert Gerding, Barbara M. Bakker, Albertus T.J. Wierenga et al. · 2022 · Nature Communications
From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
Éric Grignano, Rudy Birsen, Nicolas Chapuis, Didier Bouscary · 2020 · Frontiers in Oncology
The miR-185/PAK6 axis predicts therapy response and regulates survival of drug-resistant leukemic stem cells in CML
Hanyang Lin, Katharina Rothe, Min Chen, Andrew Wu, Artem Babaian, Ryan Yen, Jonathan Zeng, Jens Rüschmann, Oleh I. Petriv, Kieran O’Neill et al. · 2020 · Blood
Exploring the Metabolic Landscape of AML: From Haematopoietic Stem Cells to Myeloblasts and Leukaemic Stem Cells
Yashar Mesbahi, Toby N. Trahair, Richard B. Lock, Patrick Connerty · 2022 · Frontiers in Oncology
A Ferroptosis-Inducing and Leukemic Cell-Targeting Drug Nanocarrier Formed by Redox-Responsive Cysteine Polymer for Acute Myeloid Leukemia Therapy.
Yanhui Yu, Y. Meng, Xi Xu, Tong Tong, Chong He, Liying Wang, Kai-Tao Wang, Min-Yi Zhao, Xinru You, Wenwen Zhang et al. · 2023 · ACS Nano
The role of DNA-demethylating agents in cancer therapy
Parinaz Mehdipour, Tracy Murphy, Daniel Diniz De Carvalho · 2019 · Pharmacology & Therapeutics
Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
Anagha Inguva Sheth, Krysta L. Engel, Hunter Tolison, Mark Jordan Althoff, Maria L. Amaya, Anna E. Krug, Tracy N. Young, Shanshan Pei, Sweta B. Patel, Mohammad Minhajuddin et al. · 2024 · Cancer Discovery
SLC1A5 provides glutamine and asparagine necessary for bone development in mice
Deepika Sharma, Yilin Yu, Leyao Shen, Guofang Zhang, Courtney M. Karner · 2021 · eLife
Dietary methionine starvation impairs acute myeloid leukemia progression
Alan Cunningham, Ayşegül Erdem, Islam Alshamleh, Marjan Geugien, Maurien G. M. Pruis, Diego A. Pereira‐Martins, Fiona A.J. van den Heuvel, Albertus T.J. Wierenga, Hilde ten Berge, Robin Dennebos et al. · 2022 · Blood
Explainable artificial intelligence for precision medicine in acute myeloid leukemia
Marian Gimeno, Edurne San José‐Eneriz, Sara Villar, Xabier Agirre, Felipe Prósper, Angel Rubio, Fernando Carazo · 2022 · Frontiers in Immunology
Reactive Oxygen Species and Metabolism in Leukemia: A Dangerous Liaison
Marta Romo-González, Carla Ijurko, Ángel Hernández‐Hernández · 2022 · Frontiers in Immunology
An Overview of Targeted Therapies in Acute Myeloid Leukemia
Sven Turkalj, Felix A. Radtke, Paresh Vyas · 2023 · HemaSphere
A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML
He‐Zhou Guo, Rui-Xue Feng, Yanjie Zhang, Yehua Yu, Wei Lu, Jia-Jia Liu, Shaoxin Yang, Chong Zhao, Zhao-Li Zhang, Shanhe Yu et al. · 2024 · Cell Reports Medicine
Acute myeloid leukemia resistant to venetoclax-based therapy: What does the future hold?
Prajwal Dhakal, Melissa Lowe Bates, Michael H. Tomasson, Grerk Sutamtewagul, Adam J. Dupuy, Vijaya Raj Bhatt · 2022 · Blood Reviews
Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis
Malgorzata Gozdecka, Monika Dudek, Sean Wen, Muxin Gu, Richard J Stopforth, Justyna M. Rak, Aristi Damaskou, Guinevere L. Grice, Matthew A. McLoughlin, Laura Bond et al. · 2025 · Nature
Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase Inhibitors
Katharina Rothe, Artem Babaian, Naoto Nakamichi, Min Chen, Shawn C. Chafe, Akie Watanabe, Donna L. Forrest, Dixie L. Mager, Connie J. Eaves, Shoukat Dedhar et al. · 2020 · Cell stem cell
Proton export alkalinizes intracellular pH and reprograms carbon metabolism to drive normal and malignant cell growth
Cheuk Him Man, François Mercier, Nian Liu, Wentao Dong, Gregory N Stephanopoulos, Li Jiang, Yookyung Jung, Charles P. Lin, Anskar Y.H. Leung, David T. Scadden · 2021 · Blood
Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors
Runze Qiu, Yue Zhong, Qingquan Li, Yingbin Li, Hongwei Fan · 2021 · Frontiers in Cell and Developmental Biology
The Interplay Between the Genetic and Immune Landscapes of AML: Mechanisms and Implications for Risk Stratification and Therapy
Lourdes Mendez, Ryan R. Posey, Pier Paolo Pandolfi · 2019 · Frontiers in Oncology
Targeting metabolic reprogramming in chronic lymphocytic leukemia
Yu Nie, Xiaoya Yun, Ya Zhang, Xin Wang · 2022 · Experimental Hematology and Oncology
Metabolic regulation of the bone marrow microenvironment in leukemia
Binyan Xu, Rong Hu, Liang Zhao, Tong Chen, Jianyu Chen, Yuxing Hu, Yirong Jiang, Yuhua Li · 2020 · Blood Reviews
Dysregulation of mitophagy and mitochondrial homeostasis in cancer stem cells: Novel mechanism for anti‐cancer stem cell‐targeted cancer therapy
Prakash Priyadarshi Praharaj, Birija Sankar Patro, Sujit K. Bhutia · 2021 · British Journal of Pharmacology
Prospect into therapeutic potentials of Moringa oleifera phytocompounds against cancer upsurge: de novo synthesis of test compounds, molecular docking, and ADMET studies
Patrick Maduabuchi Aja, Peter Chinedu Agu, Ernest Mbamalu Ezeh, J.N. Awoke, Hilary Akobi Ogwoni, Deusdedit Tusubira, Ezebuilo Ugbala Ekpono, Ikechuku Okorie Igwenyi, Esther Ugo Alum, Emmanuel Ike Ugwuja et al. · 2021 · Bulletin of the National Research Centre/Bulletin of the National Research Center
Emerging Bone Marrow Microenvironment-Driven Mechanisms of Drug Resistance in Acute Myeloid Leukemia: Tangle or Chance?
M. Ciciarello, Giulia Corradi, D. Forte, M. Cavo, A. Curti · 2021 · Cancers
Venetoclax Resistance in Acute Myeloid Leukemia
Sylvain Garciaz, Yves Collette, Norbert Vey · 2024 · Cancers
Metabolomics in acute myeloid leukemia
Anna V. Wojcicki, Maya M. Kasowski, Kathleen M. Sakamoto, Norman James Lacayo · 2020 · Molecular Genetics and Metabolism
SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism
Anna Polak, Emilia Białopiotrowicz, Beata Krzymieniewska, Jolanta Woźniak, Marta Stojak, Magdalena Cybulska, Ewelina Kaniuga, Michał Mikuła, Ewa Jabłońska, Patryk Górniak et al. · 2020 · Cell Death and Disease
TET3 promotes AML growth and epigenetically regulates glucose metabolism and leukemic stem cell associated pathways
Alex Jose Pulikkottil, Shiva Bamezai, Tobias Ammer, Fabian Mohr, Kristin Feder, Vegi M. Naidu, Tamoghna Mandal, Ursula Kohlhofer, Leticia Quintanilla‐Martínez, Amit Sinha et al. · 2021 · Leukemia
Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthase
Benjamin J. Reisman, Hui Guo, Haley Elizabeth Ramsey, Madison T. Wright, Bradley I. Reinfeld, Paul Brent Ferrell, Gary A. Sulikowski, W. Kimryn Rathmell, Michael Robert Savona, Lars Plate et al. · 2021 · Nature Chemical Biology
Lysosomes at the Crossroads of Cell Metabolism, Cell Cycle, and Stemness
A. Nowosad, A. Besson · 2022 · International Journal of Molecular Sciences
SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming
Xi Xu, Yanhui Yu, Wenwen Zhang, Weiwei Ma, Chong He, G. Qiu, Xinyi Wang, Qiong Liu, Min-Yi Zhao, Jia-Yi Xie et al. · 2024 · Nature Cell Biology
Metabolic Rewiring in Response to Biguanides Is Mediated by mROS/HIF-1a in Malignant Lymphocytes
Hamidullah Khan, Ashish Anshu, A. Krishna Prasad, Sushmita Roy, Justin J. Jeffery, Wasakorn Kittipongdaja, David T. Yang, Stefan M. Schieke · 2019 · Cell Reports
Targeting Cellular Metabolism in Acute Myeloid Leukemia and the Role of Patient Heterogeneity
Ida Sofie Grønningsæter, Håkon Reikvam, Elise Aasebø, Sushma Bartaula-Brevik, Tor Henrik Anderson Tvedt, Øystein Bruserud, Kimberley Joanne Hatfield · 2020 · Cells
Recent advances of mitochondrial complex I inhibitors for cancer therapy: Current status and future perspectives
Yang Zhou, Jiao Zou, Jing Bo Xu, Yue Zhou, Xiaobo Cen, Yinglan Zhao · 2023 · European Journal of Medicinal Chemistry
A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia
Seyed Mohammadreza Bolandi, Mahdi Pakjoo, Peyman Beigi, Mohammad Ali Kiani, Ali Allahgholipour, Negar Goudarzi, Jamshid Sorouri Khorashad, Anna M. Eiring · 2021 · Cells
Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells
Shaowei Qiu, Vipul Sheth, Chengcheng Yan, Juan Liu, Balu K. Chacko, Hui Li, David K. Crossman, Seth D. Fortmann, Sajesan Aryal, Ashley Rennhack et al. · 2023 · Blood
Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
Nicolas Chapuis, Laury Poulain, Rudy Birsen, Jérôme Tamburini, Didier Bouscary · 2019 · Frontiers in Oncology
Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia
Myint Myat Khine Aung, Megan L. Mills, Joana Bittencourt‐Silvestre, Karen Keeshan · 2021 · Molecular Oncology
Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia
Xiaojia Niu, Katharina Rothe, Min Chen, Sarah Grasedieck, Rick Li, Sung-Eun Nam, Xiuyan Zhang, German Novakovskiy, Ye-Hyeon Ahn, Irina A. Maksakova et al. · 2021 · Blood
Intersection of Epigenetic and Metabolic Regulation of Histone Modifications in Acute Myeloid Leukemia
Abhinav Dhall, Barry M. Zee, Fangxue Yan, Mario Andres Blanco · 2019 · Frontiers in Oncology
Non‐genetic heterogeneity, altered cell fate and differentiation therapy
Alexander Charles Lewis, Lev M. Kats · 2021 · EMBO Molecular Medicine
An oncogenic enhancer encodes selective selenium dependency in AML
Kenneth Eagle, Yajian Jiang, Xiangguo Shi, Minhua Li, N. Obholzer, Tianyuan Hu, Monika W. Perez, J. Koren, A. Kitano, Joanna S. Yi et al. · 2022 · Cell Stem Cell
Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism
Germana Castelli, Elvira Pelosi, Ugo Testa · 2019 · Cancers
BCL2 Inhibition: A New Paradigm for the Treatment of AML and Beyond
Andrew H. Wei, Andrew Warwick Roberts · 2023 · HemaSphere
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia
Yan Xiao, Bingbing Hu, Yao Guo, Dengyang Zhang, Yuming Zhao, Yun Chen, Na Li, Liuting Yu · 2023 · Current Treatment Options in Oncology
Role of LncRNAs in regulating cancer amino acid metabolism
Yuhong Guo, Bin Lv, Renfeng Liu, Zhengzai Dai, Feifei Zhang, Yiping Liang, Bo Yu, Duo Zeng, Xiaobin Lv, Zhiping Zhang · 2021 · Cancer Cell International
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations
Giorgia Simonetti, Carlo Mengucci, Antonella Padella, Eugenio Fonzi, Gianfranco Picone, Claudio Delpino, Jacopo Nanni, Rossella De Tommaso, Eugenia Franchini, Cristina Papayannidis et al. · 2021 · Leukemia
HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia
Qian-Ze Dong, Yan Xiu, Yang Wang, C. Hodgson, Nick Borcherding, C. Jordan, Jane L. Buchanan, E. Taylor, B. Wagner, Mariah R. Leidinger et al. · 2022 · Nature Communications
Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes
Ying Wang, Ting Bin, Jing Yan Tang, Xiaojun Xu, Chao Lin, Bo Lü, Tiantian Sun · 2023 · Frontiers in Immunology
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia
Rebekka Wegmann, Ximena Bonilla, Ruben Casanova, Stéphane Chevrier, Ricardo Coelho, Cinzia Esposito, Joanna Ficek, Sandra Götze, Gabriele Gut, Francis Jacob et al. · 2024 · Nature Communications
Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe
Cristina Panuzzo, Aleksandar Jovanovski, Barbara Pergolizzi, Lucrezia Pironi, Serena Stanga, Carmen Fava, Daniela Cilloni · 2020 · International Journal of Molecular Sciences
Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells
Dan Huang, Changcheng Zhang, Ming Xiao, Li Xie, Weicai Chen, Yu Jiang, Yamin Yuan, Ya‐Ping Zhang, Yejun Zou, Lei Deng et al. · 2023 · Proceedings of the National Academy of Sciences
The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia
Alan Cunningham, Lieve L. Oudejans, Marjan Geugien, Diego A. Pereira‐Martins, Albertus T.J. Wierenga, Ayşegül Erdem, Dominique Sternadt, Gerwin A Huls, Jan Jacob Schuringa · 2023 · Blood Advances
A comprehensive review on signaling attributes of serine and serine metabolism in health and disease
Di Wu, Kejia Zhang, Faheem Ahmed Khan, Nuruliarizki Shinta Pandupuspitasari, Kaifeng Guan, Fei Sun, Chunjie Huang · 2024 · International Journal of Biological Macromolecules
Targeting Mitochondrial Oxidative Phosphorylation Eradicates Acute Myeloid Leukemic Stem Cells
Meixi Peng, Yongxiu Huang, Ling Zhang, Xueya Zhao, Yu Hou · 2022 · Frontiers in Oncology
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?
Serena B. Brancati, Lucia Gozzo, Giovanni Luca Romano, Calogero Vetro, Ilaria Dulcamare, Cinzia Maugeri, Marina Silvia Parisi, Laura Longo, Daniela Cristina Vitale, Francesco Di Raimondo et al. · 2021 · Cancers
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia
J. So, Alexander C. Lewis, Lorey K. Smith, K. Stanley, Rheana L Franich, David Yoannidis, Lizzy Pijpers, Pilar M. Dominguez, S. Hogg, S. Vervoort et al. · 2022 · EMBO Molecular Medicine
Resistance to targeted therapies in acute myeloid leukemia
Rabea Mecklenbrauck, Michael Heuser · 2022 · Clinical & Experimental Metastasis
Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment
Yoko Tabe, Marina Y Konopleva · 2023 · Cancer Drug Resistance
The fatty acid derivative palmitoylcarnitine abrogates colorectal cancer cell survival by depleting glutathione
Patrick C. Turnbull, Meghan C. Hughes, Christopher G. R. Perry · 2019 · American Journal of Physiology-Cell Physiology
The Amino Acid Sensor Eif2ak4/GCN2 Is Required for Proliferation of Osteoblast Progenitors in Mice
Guoli Hu, Yilin Yu, Yuning J. Tang, Colleen Wu, Fanxin Long, Courtney M. Karner · 2020 · Journal of Bone and Mineral Research
Mitochondrial oxidative phosphorylation is dispensable for survival of CD34+ chronic myeloid leukemia stem and progenitor cells
Jinsong Yan, Meng‐Ying Yang, Xuehong Zhang, Chen‐Hui Luo, Cheng-Kan DU, Yue Jiang, Xuan-Jia Dong, Zhang-Man Wang, Lixue Yang, Yi-Dong Li et al. · 2022 · Cell Death and Disease
Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities
Vilma Dembitz, Sophie C. James, Paolo Gallipoli · 2025 · Leukemia
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
Keli Lima, Diego A. Pereira‐Martins, Lívia Bassani Lins de Miranda, Juan Luiz Coelho‐Silva, Giovana da Silva Leandro, Isabel Weinhäuser, Rita de Cássia Cavaglieri, A. Leal, Wellington Fernandes da Silva, Ana Paula Lange et al. · 2022 · Blood Cancer Journal
Venetoclax in Lymphoid Malignancies: New Insights, More to Learn
Rachel Thijssen, Andrew Warwick Roberts · 2019 · Cancer Cell
BH3 Mimetics in AML Therapy: Death and Beyond?
Claudia Cerella, Mario A. Dicato, Marc F. Diederich · 2020 · Trends in Pharmacological Sciences
Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance
Sylvain Garciaz, Colombe Saillard, Yosr Hicheri, Norbert Vey · 2021 · Cancers
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
Maria Rodriguez‐Zabala, Ramprasad Ramakrishnan, Katrin Reinbach, Somadri Ghosh, Leal Oburoglu, Ton Falqués, Kishan Bellamkonda, Mats Ehinger, Pablo Peña‐Martínez, Noelia Puente‐Moncada et al. · 2023 · Blood Advances
Pyrroline-5-carboxylate reductase 1 reprograms proline metabolism to drive breast cancer stemness under psychological stress
Bai Cui, Bin He, Yanping Huang, Cenxin Wang, Huandong Luo, Jinxin Lü, Keyu Su, Xiaoyu Zhang, Yuanyuan Luo, Zhuoran Zhao et al. · 2023 · Cell Death and Disease
Venetoclax resistance in acute myeloid leukaemia—Clinical and biological insights
Boaz Nachmias, Shlomzion Aumann, Arnon Haran, Aaron David Schimmer · 2024 · British Journal of Haematology
Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia
Zhiyu Zhang, Jiayi Huang, Zhibo Zhang, Hongjie Shen, Xiaowen Tang, Depei Wu, Xiebing Bao, Guoqiang Xu, Suning Chen · 2024 · Biomarker Research
Novel copper complex CTB regulates methionine cycle induced TERT hypomethylation to promote HCC cells senescence via mitochondrial SLC25A26
Chun Jin, Yujia Li, Ying Su, Zijian Guo, Xiaoyong Wang, Shijun Wang, Feng Zhang, Zili Zhang, Jiangjuan Shao, Shizhong Zheng · 2020 · Cell Death and Disease
Arsenic Trioxide and Venetoclax Synergize against AML Progenitors by ROS Induction and Inhibition of Nrf2 Activation
Dinh Hoa Hoang, Ralf Buettner, Melissa Valerio, Lucy Y. Ghoda, Bin Zhang, Ya‐Huei Kuo, Steven T. Rosen, John Burnett, Guido Marcucci, Vinod A. Pullarkat et al. · 2022 · International Journal of Molecular Sciences
Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicity
Cristiana O’Brien, Tianyi Ling, Jacob M. Berman, Rachel Culp‐Hill, Julie A. Reisz, Vincent Rondeau, Soheil Jahangiri, Jonathan R. St‐Germain, Vinitha Macwan, Audrey Astori et al. · 2023 · Haematologica
Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer
Cuicui Liu, Lie Chen, Cai Yu-wen, Yufei Chen, Yiming Liu, Yujie Zhou, Zhi‐Ming Shao, Ke‐Da Yu · 2024 · Cell Reports Medicine